Showing results (1371-1380 of 1,833) with videos related to

Sort By:
Pageof 184
Signal Transduction and Targeted Therapy|February 6, 2025
Hepatocellular carcinoma: signaling pathways and therapeutic advancesJiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy|January 28, 2025
Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted studyFei Wang, Yongjiu Wang, Bin Xiong, et al.
Signal Transduction and Targeted Therapy|January 19, 2025
Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkageJi Eon Kim, Hyun Su Kim, Wonsik Kim, et al.
Signal Transduction and Targeted Therapy|January 9, 2025
Mitochondrial diseases: from molecular mechanisms to therapeutic advancesHaipeng Wen, Hui Deng, Bingyan Li, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Signal Transduction and Targeted Therapy|January 2, 2025
In defence of ferroptosisFrancesca Alves, Darius Lane, Triet Phu Minh Nguyen, et al.
Signal Transduction and Targeted Therapy|December 31, 2024
Malate initiates a proton-sensing pathway essential for pH regulation of inflammationYu-Jia-Nan Chen, Rong-Chen Shi, Yuan-Cai Xiang, et al.
Signal Transduction and Targeted Therapy|December 3, 2024
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trialYuxi Chen, Yuan Pan, Yanyan Xie, et al.
Signal Transduction and Targeted Therapy|December 15, 2024
Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)Xinghao Ai, Bo Jia, Zhiyi He, et al.
Signal Transduction and Targeted Therapy|November 18, 2024
EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammationYingnan Bai, Liming Chen, Fanghao Guo, et al.
Pageof 184